Iryna A Khasabova Selected Research

Iryna A Khasabova Research Topics

Disease

13	Hyperalgesia 05/2022 - 09/2007
10	Pain (Aches) 05/2022 - 10/2008
10	Neoplasms (Cancer) 12/2020 - 09/2007
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 05/2012
5	Fibrosarcoma 10/2013 - 09/2007
3	Bone Neoplasms (Bone Cancer) 12/2020 - 10/2008
3	Cancer Pain 10/2013 - 07/2011
2	Neuralgia (Stump Neuralgia) 01/2021 - 03/2019
2	Painful Neuropathy 03/2019 - 03/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2019
1	Chronic Pain 12/2014

Drug/Important Bio-Agent (IBA)

7	EndocannabinoidsIBA 05/2022 - 10/2008
5	Opioid Analgesics (Opioids)IBA 05/2022 - 07/2011
5	anandamide (arachidonylethanolamide)IBA 03/2015 - 10/2008
4	Cisplatin (Platino)FDA LinkGeneric 03/2019 - 05/2012
4	CannabinoidsIBA 03/2015 - 05/2012
3	EnzymesIBA 05/2022 - 10/2008
3	CB2 Cannabinoid ReceptorIBA 12/2014 - 07/2011
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2013 - 10/2008
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 05/2022 - 01/2019
2	Dinoprostone (PGE2)FDA Link 05/2022 - 01/2019
2	hemoglobin AAIBA 05/2022 - 01/2019
2	JZL 184IBA 05/2022 - 12/2014
2	ProstaglandinsIBA 05/2022 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 05/2022 - 03/2015
2	EstersIBA 05/2022 - 05/2012
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 09/2011 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 07/2011 - 10/2008
2	Messenger RNA (mRNA)IBA 10/2008 - 09/2007
1	Sickle HemoglobinIBA 05/2022
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 05/2022
1	AntioxidantsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 12/2020
1	resolvin D1IBA 12/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2020
1	Pioglitazone (Actos)FDA Link 03/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2019
1	CalciumIBA 03/2019
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	purinoceptor P2Y6IBA 01/2019
1	Flurbiprofen (Froben)FDA LinkGeneric 01/2019
1	PlatinumIBA 03/2015
1	CholesterolIBA 10/2013
1	GW 7647IBA 09/2012
1	GW 6471IBA 09/2012
1	5-phenylpentyl N- ((2S,3R)- 2- methyl- 4- oxo- oxetan- 3- yl)carbamateIBA 09/2012
1	AcidsIBA 05/2012
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2011
1	Cannabinoid Receptor AgonistsIBA 09/2011
1	AM 1241IBA 09/2011
1	arachidonylcyclopropylamideIBA 09/2011
1	Glycerol (Glycerine)FDA LinkGeneric 07/2011
1	Morphine (MS Contin)FDA LinkGeneric 07/2011
1	CC ChemokinesIBA 09/2007
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2007
1	Peptides (Polypeptides)IBA 09/2007
1	Capsaicin (Zostrix)FDA Link 09/2007
1	LigandsIBA 09/2007

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 05/2012
1	Intravenous Injections 05/2022
1	Therapeutics 10/2013
1	Injections 05/2012
1	Analgesia 09/2011